What's Happening?
Benjamin Wallfisch has joined Polsinelli as a shareholder in its healthcare litigation and government investigations practices, operating out of Washington, D.C., and Denver. Wallfisch previously served at the Office of Counsel to the Inspector General at the U.S. Department of Health and Human Services. His role involved providing legal analysis and advice on significant fraud and abuse laws affecting the healthcare industry, including the Federal Anti-Kickback Statute, the Physician Self-Referral Law, and the False Claims Act. Wallfisch also negotiated integrity obligations as part of False Claims Act settlements and managed self-disclosures under the OIG’s Health Care Fraud Self-Disclosure Protocol.
Why It's Important?
Wallfisch's move to Polsinelli is significant for the healthcare industry, as his expertise in fraud and abuse laws will enhance the firm's capabilities in handling complex healthcare litigation and government investigations. His experience with the Office of Counsel to the Inspector General provides him with a deep understanding of regulatory compliance and enforcement, which is crucial for healthcare providers navigating legal challenges. This transition could lead to more robust legal strategies and defenses for Polsinelli's clients, potentially impacting how healthcare fraud cases are managed and resolved.
What's Next?
Wallfisch's integration into Polsinelli's team may lead to new approaches in healthcare litigation and government investigations. His background suggests that he will focus on strengthening the firm's ability to negotiate settlements and manage compliance issues effectively. Stakeholders in the healthcare sector, including providers and legal professionals, will likely monitor how his expertise influences Polsinelli's litigation strategies and outcomes in fraud and abuse cases.
Beyond the Headlines
Wallfisch's move highlights the ongoing demand for specialized legal expertise in the healthcare sector, particularly in navigating complex regulatory environments. His role may also underscore the importance of legal compliance and proactive fraud prevention measures within healthcare organizations, potentially leading to broader industry shifts towards more stringent internal controls and transparency.
